Obinutuzumab is Effective for the Treatment of Refractory Membranous Nephropathy

Detalles Bibliográficos
Autores principales: Sethi, Supreet, Kumar, Sanjeev, Lim, Kathlyn, Jordan, Stanley C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Research Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7486170/
https://www.ncbi.nlm.nih.gov/pubmed/32954076
http://dx.doi.org/10.1016/j.ekir.2020.06.030
_version_ 1783581292370067456
author Sethi, Supreet
Kumar, Sanjeev
Lim, Kathlyn
Jordan, Stanley C.
author_facet Sethi, Supreet
Kumar, Sanjeev
Lim, Kathlyn
Jordan, Stanley C.
author_sort Sethi, Supreet
collection PubMed
description
format Online
Article
Text
id pubmed-7486170
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-74861702020-09-17 Obinutuzumab is Effective for the Treatment of Refractory Membranous Nephropathy Sethi, Supreet Kumar, Sanjeev Lim, Kathlyn Jordan, Stanley C. Kidney Int Rep Research Letter Elsevier 2020-07-03 /pmc/articles/PMC7486170/ /pubmed/32954076 http://dx.doi.org/10.1016/j.ekir.2020.06.030 Text en © 2020 International Society of Nephrology. Published by Elsevier Inc. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Research Letter
Sethi, Supreet
Kumar, Sanjeev
Lim, Kathlyn
Jordan, Stanley C.
Obinutuzumab is Effective for the Treatment of Refractory Membranous Nephropathy
title Obinutuzumab is Effective for the Treatment of Refractory Membranous Nephropathy
title_full Obinutuzumab is Effective for the Treatment of Refractory Membranous Nephropathy
title_fullStr Obinutuzumab is Effective for the Treatment of Refractory Membranous Nephropathy
title_full_unstemmed Obinutuzumab is Effective for the Treatment of Refractory Membranous Nephropathy
title_short Obinutuzumab is Effective for the Treatment of Refractory Membranous Nephropathy
title_sort obinutuzumab is effective for the treatment of refractory membranous nephropathy
topic Research Letter
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7486170/
https://www.ncbi.nlm.nih.gov/pubmed/32954076
http://dx.doi.org/10.1016/j.ekir.2020.06.030
work_keys_str_mv AT sethisupreet obinutuzumabiseffectiveforthetreatmentofrefractorymembranousnephropathy
AT kumarsanjeev obinutuzumabiseffectiveforthetreatmentofrefractorymembranousnephropathy
AT limkathlyn obinutuzumabiseffectiveforthetreatmentofrefractorymembranousnephropathy
AT jordanstanleyc obinutuzumabiseffectiveforthetreatmentofrefractorymembranousnephropathy

Ejemplares similares